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An efficient synthesis of 3-oxoisoindolines is described from 2-carboxybenzaldehyde, TMSCN and 
benzylic or aliphatic amines using a Strecker approach with OSU-6 as the catalyst.  The reaction can be 
tuned to generate two different products: a substituted (±)-3-oxoisoindoline-1-carbonitrile at 23 °C or the 
corresponding C1 primary amide at 78 °C.  Aromatic amines divert from this reactivity to give 
isobenzofuranone derivatives.  The formation of primary amides in these Strecker cyclizations has not 
been previously reported.  The OSU-6 catalyst is a newly developed MCM-41 type hexagonal 
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Introduction 
Isoindolinones are recognized as valuable building blocks for various drug intermediates and 
natural products.1-3 These systems are extensively used in pharmaceuticals for the treatment of 
hypertension,4 inflammation,5 psychosis,6, 7 pain,8 anxiety,9 cancer,10, 11 bacterial infections12 and ulcers.13 
They are also found in powerful inhibitors of tumor necrosis factor production.14  The commercial drug 
indoprofen, which was used as an anti-inflammatory agent in the 1970s, contains an isoindolinone ring in 
its core structure.15, 16 Apart from their bioactivity, these heterocycles also find utility as molecular 
switches due to their electrochemical properties.17  Despite their potential medicinal and electrochemical 
applications, relatively few approaches exist for the preparation of isoindolinone rings and these generally 
require multistep syntheses or expensive metal catalysts.  
In recent years, multicomponent reactions have emerged as powerful tools in the field of organic 
syntheses.  This is due to their ability to generate diverse and complex targets in fewer steps from readily 
available starting materials.18   Multicomponent reactions have unique advantages due to operational 
simplicity, green protocols and low cost.  
The Strecker reaction is regarded as one of the first multicomponent reaction and has been widely 
employed in the synthesis amino acids and α-aminonitriles.19, 20 Although Strecker reactions generate 
specific targets, the presence of neighbouring reactive sites can lead to intramolecular reactions that form 
nitrogen heterocycles.  In this project, we have taken advantage of the neighbouring functionality in 2-
carboxybenzaldehyde and extended this multicomponent reaction to the synthesis of 3-oxoisoindoline 
derivatives.  
 4 
Earlier work has applied the Strecker protocol to the preparation of isoindolinones rings, but with 
only modest success.  The Opatz group was the first to employ this approach by reacting 2-
carboxybenzaldehyde with methylamine hydrochloride and potassium cyanide in methanol containing 
acetic acid.21  The single example reported produced (±)-2-methyl-3-oxoisoindoline-1-carbonitrile in 
moderate yield along with several by-products that made product isolation difficult.  Recently, Hu and co-
workers reported a similar route using trimethylsilyl cyanide (TMSCN) as the cyanide source in refluxing 
ethanol with sulfamic acid as the catalyst.22 Though this procedure afforded acceptable yields, limitations 
were encountered with respect to the amine reactants allowed in the cyclization.  
Over the years, our research group has been involved in synthesizing heterocycles using 
environmentally benign approaches.  Among these targets, benzoxazoles, benzothiazoles, 
benzimidazoles23 and oxadiazoles24 have been prepared using ammonium chloride as the catalyst.  The 
current study has successfully developed a green approach to the formation of (±)-3-oxoisoindoline-1-
carbonitriles using OSU-6, and reports a novel cyanide to amide conversion.   The method has been 
further extended to 2-acetylbenzoic acid, which cyclizes with comparable efficiency.  
OSU-6, a MCM-41 type hexagonal mesoporous silica developed at Oklahoma State University 
by AlOthman and Apblett,25 piqued our interest as a potential catalyst for this process due to its strong 
Lewis acid properties and high surface area.  This material is more robust than traditional MCM-41 due to 
its greater channel wall thickness, and offers a relatively large pore size (> 8 nm) and volume (> 1.7 
cm3/g).  In this study, we have explored the use of OSU-6 for the synthesis of isoindolinones from 2-
carboxybenzaldehyde, TMSCN and a series of amines and found that complete conversion can be 
accomplished in high yields at room temperature.  Moreover, this heterogeneous catalyst can be readily 
regenerated and reused without significant loss of activity.  Finally, the current method minimizes waste 
by avoiding tedious workup procedures as most products were isolated by filtration. 
 Results and discussion 
The reaction of 2-carboxybenzaldehyde (1) with benzylamine (2a) and TMSCN in anhydrous 
ethanol was used as a model reaction to evaluate catalysts for the preparation of (±)-3-oxoisoindoline-1-
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carbonitrile 3a under various solvent and temperature conditions (Table I).  In control experiments 
without catalyst, this transformation gives low conversion to 3a and a varying number of by-products.  
The catalysts screened were NH4Cl, dry amberlyst-15 (A-15), p-TsOH, Bi(OTf)3, SiO2 and OSU-6, while  
the solvents included methanol, ethanol (95%) and 100%), tetrahydrofuran, dioxane and acetonitrile.  In  
 










1 NH4Cl EtOH 78 < 5 
2 NH4Cl  CH3CN 30 < 5 
3 A-15 EtOH 78 15 
4 A-15 MeOH 65 22 
5  Bi(OTf)3 THF 25 20 
6  Bi(OTf)3 dioxane 80 10 
7  p-TsOH THF 67 51 
8 p-TsOH CH3CN 81 46 
9 OSU-6  EtOH 25 94 
10 OSU-6  CH3CN 25 64 
11 SiO2 EtOH 25 60 
12 SiO2 EtOH 78 70 
 
each case, the reaction was performed using 10-wt% of the catalyst.   These initial trials established that 
OSU-6 in 100% ethanol at room temperature produced the highest yield of 3a.  Encouraged by this result, 
we endeavoured to determine the optimum catalyst loading.  To this end, comparison of 1, 5, 10, and 20-











Once the optimized conditions were established, the method was applied to a broad range of amines to 
define the substrate scope (Table II).  Initially, benzylamines 2a-f were evaluated. The excellent yields 
obtained with these substrates revealed that isoindolinone cyclizations were unaffected by the presence of 
electron donating (CH3, OMe) or electron withdrawing (F, Cl, CF3) substituents at the meta or a para 
positions of the aromatic ring.  Subsequent examination of a series of aliphatic amines, including 2-
phenylethylamine (2g), allylamine (2h), cyclopropylamine (2i) and ethylamine (2j), also afforded the 
 
Table II.  Formation of (±)-2-alkyl-3-oxoisoindoline-1-carbonitriles 
 






2a: C6H5CH2 3a 23 60 94 
2b: 4-ClC6H4CH2 3b 23 60 89 
2c: 4-FC6H4CH2 3c 23 90 90 
2d: 3-MeOC6H4CH2 3d 23 20 94 
2e: 4-MeOC6H4CH2 3e 23 30 95 
2f: 4-CF3C6H4CH2 3f 78
a 120 86 
2g: C6H5CH2CH2 3g 23 120 76 
2h: CH2=CH-CH2 3h 23 120 84 
2i: cyclopropyl 3i 23 180 82 
2j: ethyl 3j 23 90 78 
  aThis reaction required heating, presumably due to the strong  
  electron withdrawing CF3 substituent. 
 
cyclized products in excellent yields.  Workup was performed via a four-step sequence involving (1) 
filtration of the crude product containing the catalyst, (2) dissolution of the product in ethyl acetate, (3) 











Although products 3a-j were generally formed in < 3 hours at room temperature, we decided to 
explore temperature effects on the rate of reaction.  Interestingly, under reflux conditions, reaction of 1 
with 2a and TMSCN produced a white precipitate within 30 minutes. Thin layer chromatography (TLC) 
indicated this material to be significantly different from isoindolinone 3a.  Isolation of the precipitate and 
complete spectral analysis identified this product as primary amide 4a.  We repeated the cyclization 
reactions for a selection of benzyl and aliphatic amines at reflux and found that all furnished primary 
amides in excellent yields as shown in Table III. 
 
Table III.   Formation of (±)-2-alkyl-3-oxoisoindoline-1-carboxamides 
 






2a: C6H5CH2 4a 78     60 92 
2b: 4-ClC6H4CH2 4b 78     60 87 
2d: 3-MeOC6H4CH2 4c 78     30 92 
2e: 4-MeOC6H4CH2 4d 78   120 85 
2k: 4-MeC6H4CH2 4e 78     20 94 
2l:  cyclohexyl 4f 78   120 82 
2m: n-hexyl 4g 78     90 75 
2n: isobutyl 4h 78   120 78 
 
Once our study with benzyl and aliphatic amines was complete, we further explored the 
behaviour of aromatic amines.  An initial study of 1 with aniline (5a), TMSCN and OSU-6 in refluxing 
anhydrous ethanol failed to give the expected isoindolinone, but instead, gave the isobenzofuranone 
derivative 6a.  This transformation has been previously reported from 1 by heating with anilines in acetic 










generality of this divergent pathway, affording high yields of 6b-e, respectively, after 30 minutes (Table 
IV). 
  












5a: C6H5 6a 78 30 92 
5b: 3-ClC6H4 6b 78 30 89 
5c: 4-MeOC6H4 6c 78 30 92 
5d: 4-CF3C6H4 6d 78 30 95 
5e: 4-NO2C6H4 6e 78 30 90 
           aThis reaction proceeds in the presence of OSU-6 without  
         added TMSCN. 
 
 
The reactivity of 2-acetylbenzoic acid (7) was also assessed using the standard room temperature 
protocol with amines 2. This process was more difficult to control, and thus, it was important to follow 
the reaction progress closely by TLC.  In general, the conversion proceeded cleanly to give nitriles 8a-f in 
























2a: C6H5CH2  8a 23 60 92 
2b: 4-ClC6H4CH2 8b 23 60 89 
2c: 4-FC6H4CH2 8c 23 60 92 
2h: CH2=CH-CH2 8d 23 20 94 
2j:  cyclopropyl 8e 23 30 95 
2k: 4-MeC6H4CH2 8f 23 90 90 
 
 
Repeating the reactions of 7 with 2 at higher temperature afforded amide products despite the 
steric hindrance of the nitrile intermediates.  An extended series of substrates was studied to generate 
products 9a-n.   At reflux, the formation of these primary amides was ordinarily complete in less than 2 




































Several details were noted during our study:  (1) traces of water in the amines tended to accelerate 
amide formation, while dry amines slowed this process to give better reaction control and (2) deliberate 
addition of water to the reaction mixture did not produce clean amide products.  Based on these 
observations, it appears that water adsorbed into the pores of OSU-6 is most important for the nitrile 
hydrolysis.  This water remains in the pores after the initial condensation to form the nitrile or is ushered 
in by wet reagents or solvents.  Water added to the reaction after exposure of the catalyst to anhydrous 














2a: C6H5CH2 9a 78     60 92 
2b: 4-ClC6H4CH2 9b 78     60 89 
2c: 4-FC6H4CH2 9c 78     60 85 
2d: 3-MeOC6H4CH2 9d 78     20 94 
2e: 4-MeOC6H4CH2 9e 78     30 95 
2f: 4-CF3C6H4CH2 9f 78   120 86 
2g: C6H5CH2CH2 9g 78   120 86 
2h: CH2=CH-CH2 9h 78   120 84 
2i: cyclopropyl 9i 78   180 83 
2j: ethyl 9j 78     90 78 
2k: 4-MeC6H4CH2 9k 78     90 90 
2l: cyclohexyl 9l 78     60 85 
2m: n-hexyl 9m 78     45 92 
2n: isobutyl 9n 78   120 76 
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reactants does not efficiently displace these molecules from the pores and, thus is not immediately 
available for hydrolysis of the initially formed nitrile.      
To reduce the environmental impact of the current transformation, we sought to develop a 
protocol to permit regeneration of the OSU-6 catalyst.  Following the reaction to prepare 3a, two 
procedures were evaluated for reactivating the catalyst.  Attempts to reuse the catalyst immediately after 
removal from the crude product and washing with ethyl acetate resulted in a significant loss of activity.  
On the other hand, when the catalyst was filtered and washed with copious amounts of 1:1 ethanol:water, 
followed by drying at 200 oC under vacuum for 14 hours, catalytic activity was almost fully restored.   
 
    Figure 1.  Comparison of the catalyst activity following regeneration by washing with ethyl acetate 






In summary, we have developed a simple and environmentally benign method for the synthesis of 
3-oxoisoindoline rings by using OSU-6, a MCM-41 type hexagonal mesoporous silica catalyst.  The 
method does not require tedious workup procedures and the product can be obtained by a simple four-step 
sequence.  The reaction can be tuned to generate (±)-2-alkyl-3-oxoisoindoline-1-carbonitriles at room 
temperature or the corresponding C1 primary amides under reflux conditions.  The clean hydrolysis of 
nitriles to amides in these substituted 3-oxoisoindolines appears to be the first report of this 
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control of these reactions is contingent on the use of dry reagents as attempts to employ an older samples 
of hygroscopic amines or solvents lead to acceleration of the nitrile to amide conversion.  The method has 
also been extended to 2-acetylbenzoic acid to prepare (±)-1-methyl-2-alkyl-3-oxoisoindoline-1-
carbonitriles or carboxamides, but these reactions must be closely monitored since they are more difficult 
to control.  
Experimental Section 
Commercial anhydrous ethanol was stored under dry nitrogen and transferred by syringe into reactions 
when needed.  All other commercial reagents were used as received.  Unless otherwise specified, all 
reactions were run under dry nitrogen in oven-dried glassware.  Reactions were monitored by thin layer 
chromatography on silica gel GF plates (Analtech No. 21521); band elution was monitored using a hand 
held UV lamp.  Melting points were uncorrected.   FT-IR spectra were run as thin films on NaCl disks.  
Unless otherwise indicated, 1H- and 13C-NMR spectra were measured at 400 MHz and 100 MHz, 
respectively, in the indicated solvents using (CH3)4Si as the internal standard; coupling constants (J) are 
given in Hz.  High-resolution mass spectra (HRMS) were determined using a Thermo LTQ-OrbitrapXL 
mass spectrometer. 
General experimental procedure to prepare 3 and 7. 
To a stirred solution of 1 or 6 (1.0 mmol) in 10 mL dry ethanol (10 mL) was added amine 2 (1.05 mmol) 
and OSU-6 (5-wt%), followed by TMSCN (1.05 mmol) and the solution was stirred at room temperature 
for a period of 30-120 min.  In most cases, the product was observed as a solid.   The crude reaction 
mixture was cooled in an ice bath and filtered.  The filtered product was then washed with cold ethanol 
(10 mL) and hexanes (10 mL).  After drying, the OSU-6 was removed by dissolving the product in ethyl 
acetate (50 mL) and filtering.  The organic layer was concentrated under vacuum to afford the 3-
oxoisoindoline-1-carbonitrile products as solids.  In cases where the product was not a solid, the product 
was directly concentrated along with 1-2 g of silica gel and purified on a 2.5-cm × 10-cm silica gel 
column eluted with increasing concentrations of ethyl acetate in hexanes to afford nitriles 3 or 7 in the 
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yields shown in Tables II and V.  (Note:  The amines used in the reactions must be anhydrous.  Traces of 
water in the amines will lead to amides 4 and 9 as minor products at room temperature). 
(±)-2-Benzyl-3-oxoisoindoline-1-carbonitrile (3a).  Isolated as a white solid, mp 91-92 °C; IR: 2245, 
1707 cm-1; 1H NMR (CDCl3): δ 7.93 (d, J = 7.3 Hz, 1H), 7.64 (m, 2H), 7.58 (d, J = 7.7 Hz, 1H), 7.35 (m, 
5H), 5.50 (d, J = 15.0 Hz, 1H), 5.08 (s, 1H), 4.30 (d, J = 15.0 Hz, 1H); 13C NMR (CDCl3) δ 166.9, 136.8, 
135.2, 133.0, 131.2, 130.5, 129.2, 128.6, 128.4, 124.7, 123.1, 114.5, 48.9, 45.0.  HRMS (ESI) calcd for 
C16H13N2O [M + H]+: 249.1028, found: 249.1036. 
(±)-2-(4-Chlorobenzyl)-3-oxoisoindoline-1-carbonitrile (3b).  Isolated as a white solid, mp 139-140 °C; 
IR: 2242, 1708 cm-1; 1H NMR (DMSO-d6): δ 7.85 (d, J = 7.5 Hz, 1H), 7.79 (m, 2H), 7.69 (t, J = 7.3 Hz, 
1H), 7.44 (d, J = 8.2 Hz, 2H), 7.38 (d, J = 8.2 Hz, 2H), 5.96 (s, 1H), 4.96 (d, J = 15.7 Hz, 1H), 4.68 (d, J 
= 15.7 Hz, 1H); 13C NMR (DMSO-d6) δ 167.2, 138.4, 135.6, 133.7, 132.8, 130.8, 130.4, 130.3, 129.1, 
124.3, 124.2, 116.2, 50.2, 44.8.  HRMS (ESI) calcd for C16H12ClN2O [M + H]+: 283.0638, found: 
283.0645. 
(±)-2-(4-Fluorobenzyl)-3-oxoisoindoline-1-carbonitrile (3c).  Isolated as a white solid, mp 110-111 °C; 
IR: 2250, 1707 cm-1; 1H NMR (DMSO-d6): δ 7.85 (d, J = 7.5 Hz, 1H), 7.79 (m, 2H), 7.69 (t, J = 7.3 Hz, 
1H), 7.41 (m, 2H), 7.21 (t, J = 8.7 Hz, 2H), 5.94 (s, 1H), 4.95 (d, J = 15.5 Hz, 1H), 4.66 (d, J = 15.5 Hz, 
1H); 13C NMR (DMSO-d6): δ 167.1, 162.2 (d, J = 244.4 Hz), 138.3, 133.6, 132.8, 130.8 (2C), 130.7 (d, J 
= 8.0 Hz), 124.3, 124.2, 116.2, 116.0 (d, J = 21.0 Hz), 50.1, 44.7.  HRMS (ESI) calcd for C16H12FN2O [M 
+ H]+: 267.0934, found: 267.0930. 
(±)-2-(3-Methoxybenzyl)-3-oxoisoindoline-1-carbonitrile (3d).  Isolated as a white solid, mp 102-103 
°C; IR: 2837, 2247, 1706 cm-1; 1H NMR (DMSO-d6): δ 7.85 (d, J = 7.5 Hz, 1H), 7.79 (m, 2H), 7.68 (t, J = 
7.3 Hz, 1H), 7.30 (t, J = 7.7 Hz, 1H), 6.92 (s, 1H), 6.90 (m, 2H), 5.92 (s, 1H), 5.01 (d, J = 15.5 Hz, 1H), 
4.57 (d, J = 15.5 Hz, 1H), 3.75 (s, 3H); 13C NMR (DMSO-d6) δ 167.1, 160.0, 138.3, 138.0, 133.6, 130.9, 
130.8, 130.3, 124.3, 124.2, 120.5, 116.2, 114.1, 113.7, 55.5, 50.1, 45.3.  HRMS (ESI) calcd for 
C17H15N2O2 [M + H]+: 279.1134, found: 279.1141. 
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(±)-2-(4-Methoxybenzyl)-3-oxoisoindoline-1-carbonitrile (3e).  Isolated as a white solid, mp 152-153 
°C; IR: 2832, 2248, 1693 cm-1; 1H NMR (DMSO-d6): δ 7.84 (d, J = 7.5 Hz, 1H), 7.77 (m, 2H), 7.68 (t, J = 
7.3 Hz, 1H), 7.29 (d, J = 8.4 Hz, 2H), 6.94 (d, J = 8.4 Hz, 2H), 5.85 (s, 1H), 4.96 (d, J = 15.2 Hz, 1H), 
4.52 (d, J = 15.2 Hz, 1H), 3.75 (s, 3H); 13C NMR (DMSO-d6): δ 166.5, 158.9, 137.8, 133.1, 130.5, 130.3, 
129.5, 127.8, 123.8, 123.6, 115.7, 114.1, 55.0, 49.4, 44.3.  HRMS (ESI) calcd for C17H15N2O2 [M + H]+: 
279.1134, found: 279.1137. 
(±)-2-[(4-Trifluoromethyl)benzyl]-3-oxoisoindoline-1-carbonitrile (3f).  Isolated as a white solid, mp 
88-89 °C; IR: 2265, 1710 cm-1; 1H NMR (DMSO-d6):  δ 7.87 (d, J = 7.6 Hz, 1H), 7.81 (m, 2H), 7.75 (d, J 
= 8.0 Hz, 2H), 7.70 (t, J = 7.3 Hz, 1H), 7.58 (d, J = 8.0 Hz, 2H), 6.02 (s, 1H), 5.06 (d, J = 16.0 Hz, 1H), 
4.80 (d, J = 16.0 Hz, 1H); 13C NMR (DMSO-d6): δ 167.3, 141.5, 138.4, 133.7, 130.8, 130.7, 129.1, 128.7 
(q, J = 14.1 Hz), 126.0 (q, J = 4.0 Hz), 124.7 (q, J = 272.7 Hz), 124.3, 124.2, 116.2, 50.4, 45.1.  HRMS 
(ESI) calcd for C17H12F3N2O [M + H]+: 317.0902, found: 317.0911. 
(±)-3-Oxo-2-(2-phenylethyl)isoindoline-1-carbonitrile (3g).  Isolated as an off-white solid, mp 110-111 
°C; IR: 2248, 1706 cm-1; 1H NMR (CDCl3): δ 7.89 (d, J = 7.4 Hz, 1H), 7.65 (t, J = 7.4 Hz, 1H), 7.59 (t, J 
= 7.4 Hz, 1H), 7.55 (d, J = 7.5 Hz, 1H), 7.29 (m, 5H), 4.90 (s, 1H), 4.33 (dt, J = 14.4, 6.6 Hz, 1H), 3.64 
(dt, J = 14.4, 7.7 Hz, 1H), 3.07 (m, 2H); 13C NMR (CDCl3): δ 167.1, 138.0, 136.8, 132.8, 131.3, 130.4, 
128.9, 128.7, 127.0, 124.4, 123.0, 114.8, 50.3, 43.0, 34.5.  HRMS (ESI) calcd for C17H15N2O [M + H]+: 
263.1184, found: 263.1190. 
(±)-2-Allyl-3-oxoisoindoline-1-carbonitrile (3h).  Isolated as an off-white solid, mp 83-84 °C; IR: 2244, 
1704 cm-1; 1H NMR (CDCl3): δ 7.91 (d, J = 7.5 Hz, 1H), 7.67 (m, 3H), 5.86 (m, 1H), 5.37 (m, 2H), 5.35 
(s, 1H), 4.79 (dd, J = 15.4, 4.6 Hz, 1H), 3.91 (dd, J = 15.4, 8.0 Hz, 1H); 13C NMR (CDCl3) δ 166.8, 
136.8, 133.0, 131.4, 131.3, 130.5, 124.6, 123.1, 120.3, 114.6, 49.1, 43.8.  HRMS (ESI) calcd for 
C12H11N2O [M + H]+: 199.0871, found: 199.0877. 
(±)-2-Cyclopropyl-3-oxoisoindoline-1-carbonitrile (3i). Isolated as a pale yellow solid, mp 78-79 °C; 
IR: 2247, 1710 cm-1; 1H NMR (CDCl3): δ 7.85 (d, J = 7.5 Hz, 1H), 7.72-7.63 (m, 1H), 7.62 (d, J = 7.3 Hz, 
1H), 7.59 (t, J = 7.3 Hz, 1H), 5.29 (s, 1H), 2.87 (tt, J = 7.2, 3.9 Hz, 1H), 1.18 (m, 1H), 1.08 (m, 1H), 1.01 
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(m, 1H), 0.90 (m, 1H); 13C NMR (CDCl3): δ 168.2, 136.8, 133.0, 131.7, 130.4, 124.4, 123.0, 115.3, 51.1, 
24.6, 6.6, 5.4.  HRMS (ESI) calcd for C12H11N2O [M + H]+: 199.0871, found: 199.0880. 
(±)-2-Ethyl-3-oxoisoindoline-1-carbonitrile (3j).  Isolated as a white solid, mp 98-99 °C; 2285, 1771 
cm-1; 1H NMR (CDCl3): δ 7.89 (d, J = 7.6 Hz, 1H), 7.71 (t, J = 7.5 Hz, 1H), 7.60 (overlapping d and t, J = 
7.6 Hz, 2H), 6.37 (s, 1H), 4.00 (dq, J = 9.4, 7.1 Hz, 1H), 3.87 (dq, J = 9.4, 7.1 Hz, 1H), 1.33 (t, J = 7.1 
Hz, 3H); 13C NMR (CDCl3): δ 168.7, 145.1, 134.4, 130.8, 127.2, 125.4, 123.4, 102.3, 77.2, 65.9, 15.1.  
HRMS (ESI) calcd for C11H11N2O [M + H]+: 187.0871, found: 187.0874. 
General experimental procedure to prepare 4 and 8. 
To a stirred solution of 1 or 7 (1.0 mmol) in 10 mL dry ethanol (10 mL) was added amine 2 (1.05 mmol) 
and OSU-6 (5-wt%), followed by TMSCN (1.1 mmol) and the solution was refluxed for a period of 1-3 h.  
In most cases, the product was a solid.   The crude reaction mixture was cooled in an ice bath and filtered.  
The filtered product was washed with cold ethanol (10 mL) and hexanes (10 mL).  After drying, the 
product was re-dissolved in hot ethyl acetate (75 mL) and filtered to remove the catalyst.  The organic 
layer was concentrated under vacuum to afford the 3-oxoisoindoline-1-carboxamide products.  In cases 
where the product was not a solid the product was directly concentrated along with 1-2 g of silica gel and 
purified on a 2.5-cm × 10-cm silica gel column eluted with increasing concentrations of ethyl acetate in 
hexanes to afford the products 4 or 9 in the yields shown in Tables III and VI.  
(±)-2-Benzyl-3-oxoisoindoline-1-carboxamide (4a).  Isolated as a white solid, mp 229-230 °C; IR: 3341, 
3194, 1671 cm-1; 1H NMR (DMSO-d6): δ 8.05 (br s, 1H), 7.76 (d, J = 7.4 Hz, 1H), 7.63 (t, J = 7.4 Hz, 
1H), 7.56 (d, J = 7.5 Hz, 2H), 7.56 (obscured, 1H), 7.36 (t, J = 7.3 Hz, 2H), 7.30 (t, J = 7.2 Hz, 1H), 7.24 
(d, J = 7.3 Hz, 2H), 5.25 (d, J = 15.3 Hz, 1H), 4.91 (s, 1H), 4.02 (d, J = 15.3 Hz, 1H); 13C NMR (DMSO-
d6): δ 168.8, 168.3, 141.9, 137.4, 132.4, 131.8, 129.3, 129.2, 128.3, 128.0, 123.6, 123.0, 62.6, 44.7.  
HRMS (ESI) calcd for C16H15N2O2 [M + H]+: 267.1134, found: 267.1139. 
(±)-2-(4-Chlorobenzyl)-3-oxoisoindoline-1-carboxamide (4b).  Isolated as a white solid, mp 248-249 
°C; IR: 3333, 3189, 1681 cm-1; 1H NMR (DMSO-d6): δ 8.03 (br s, 1H), 7.76 (d, J = 7.3 Hz, 1H), 7.64 (t, J 
= 7.4 Hz, 1H), 7.57 (t, J = 8.2 Hz, 2H), 7.56 (obscured, 1H), 7.42 (d, J = 8.2 Hz, 2H), 7.27 (d, J = 8.2 Hz, 
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2H), 5.18 (d, J = 15.5 Hz, 1H), 4.93 (s, 1H), 4.07 (d, J = 15.5 Hz, 1H); 13C NMR (DMSO-d6): δ 168.7, 
168.4, 142.0, 136.5, 132.5, 132.4, 131.7, 130.2, 129.3, 129.1, 123.6, 123.0, 62.7, 44.2.  HRMS (ESI) 
calcd for C16H14ClN2O2 [M + H]+: 301.0744, found: 301.0760. 
(±)-2-(3-Methoxybenzyl)-3-oxoisoindoline-1-carboxamide (4c).  Isolated as a pale yellow solid, mp 
252-253 °C; IR: 3321, 3133, 1669 cm-1; 1H NMR (DMSO-d6): δ 8.06 (br s, 1H), 7.76 (d, J = 7.4 Hz, 1H), 
7.64 (t, J = 7.6 Hz, 1H), 7.56 (d, J = 7.5 Hz, 2H), 7.55 (obscured, 1H), 7.28 (t, J = 8.0 Hz, 1H), 6.87 (d, J 
= 8.8 Hz, 1H), 6.79 (s, 1H), 6.78 (obscured, 1H), 5.21 (d, J = 15.2 Hz, 1H), 4.92 (s, 1H), 3.99 (d, J = 15.2 
Hz, 1H), 3.73 (s, 3H); 13C NMR (DMSO-d6): δ 168.8, 168.3, 160.0, 141.9, 138.9, 132.4, 131.7, 130.4, 
129.3, 123.6, 123.0, 120.4, 114.0, 113.4, 62.6, 55.5, 44.7.  HRMS (ESI) calcd for C17H17N2O3 [M + H]+: 
297.1239, found: 279.1244. 
(±)-2-(4-Methoxybenzyl)-3-oxoisoindoline-1-carboxamide (4d).  Isolated as an off-white solid, mp 
210-211 °C; IR: 3350, 3184, 1678 cm-1; 1H NMR (DMSO-d6): δ 8.03 (br s, 1H), 7.74 (d, J = 7.4 Hz, 1H), 
7.62 (t, J = 7.3 Hz, 1H), 7.55 (d, J = 7.8 Hz, 2H), 7.54 (obscured, 1H), 7.17 (d, J = 8.2 Hz, 2H), 6.92 (d, J 
= 8.2 Hz, 2H), 5.18 (d, J = 15.0 Hz, 1H), 4.85 (s, 1H), 3.95 (d, J = 15.0 Hz, 1H), 3.73 (s, 3H); 13C NMR 
(DMSO) δ 168.8, 168.2, 159.1, 141.9, 132.3, 131.9, 129.8, 129.2, 123.5, 123.0, 114.6, 62.4, 55.6, 44.1 
(one aromatic C unresolved).  HRMS (ESI) calcd for C17H17N2O3 [M + H]+: 297.1239, found: 279.1248. 
(±)-2-(4-Methylbenzyl)-3-oxoisoindoline-1-carboxamide (4e).  Isolated as a white solid, mp 230-231 
°C; IR: 3356, 3195, 1667 cm-1; 1H NMR (DMSO-d6): δ 8.03 (br s, 1H), 7.75 (d, J = 7.4 Hz, 1H), 7.63 (t, J 
= 7.4 Hz, 1H), 7.55 (d, J = 8.0 Hz, 2H), 7.54 (obscured, 1H), 7.17 (d, J = 7.7 Hz, 2H), 7.12 (d, J = 7.7 Hz, 
2H), 5.21 (d, J = 15.1 Hz, 1H), 4.87 (s, 1H), 3.96 (d, J =15.1 Hz, 1H), 2.28 (s, 3H); 13C NMR (DMSO-d6) 
δ 168.8, 168.2, 141.9, 137.2, 134.3, 132.3, 131.8, 129.8, 129.2, 128.4, 123.5, 123.0, 62.5, 44.4, 21.1.  
HRMS (ESI) calcd for C17H17N2O2 [M + H]+: 281.1290, found: 281.1292. 
(±)-2-Cyclohexyl-3-oxoisoindoline-1-carboxamide (4f).  Isolated as a yellow solid, mp 209-210 °C; IR: 
3301, 3161, 1674 cm-1; 1H NMR (DMSO-d6): δ 8.01 (br s, 1H), 7.67 (d, J = 7.4 Hz, 1H), 7.60 (t, J = 7.4 
Hz, 1H), 7.52 (d, J = 7.5 Hz, 1H), 7.50 (t, J = 7.6 Hz, 1H), 7.43 (br s, 1H), 5.21 (s, 1H), 3.88 (t, J = 12.0 
Hz, 1H), 1.91 (d, J = 12.5 Hz, 1H), 1.78 (m, 3H), 1.70-1.45 (complex, 3H), 1.33 (m, 2H), 1.10 (q, J = 
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12.9 Hz, 1H); 13C NMR (DMSO-d6): δ 170.6, 168.4, 142.7, 132.7, 132.0, 129.0, 123.1, 122.4, 62.2, 53.0, 
49.1, 30.8, 30.6, 25.8, 25.7.  HRMS (ESI) calcd for C15H19N2O2 [M + H]+: 259.1447, found: 259.1462. 
(±)-2-Hexyl-3-oxoisoindoline-1-carboxamide (4g).  Isolated as off white solid, mp 142-143 °C; IR: 
3301, 3161, 1674 cm-1; 1H NMR (DMSO-d6): δ 8.05 (br s, 1H), 7.69 (d, J = 7.4 Hz, 1H), 7.62 (m, 2H), 
7.52 (m, 2H), 5.18 (s, 1H), 3.83 (dt, J = 13.9, 7.9 Hz, 1H), 3.00 (m, 1H), 1.56 (m, 2H), 1.27 (m, 6H), 0.86 
(distorted t, J = 6.5 Hz, 3H); 13C NMR (DMSO-d6): δ 169.2, 168.3, 142.1, 132.3, 132.0, 129.1, 123.3, 
122.8, 63.1, 41.0, 31.4, 27.8, 26.5, 22.5, 14.4.  HRMS (ESI) calcd for C15H21N2O2 [M + H]+: 261.1603, 
found: 261.1612. 
(±)-2-Isobutyl-3-oxoisoindoline-1-carboxamide (4h).  Isolated as an off-white solid, mp 191-192 °C; 
IR: 3337, 3181, 1676 cm-1; 1H NMR (DMSO-d6): δ 8.08 (br s, 1H), 7.70 (d, J = 7.5 Hz, 1H), 7.62 (m, 
2H), 7.54 (m, 2H), 5.19 (s, 1H), 3.65 (dd, J  = 13.8, 9.4 Hz, 1H), 2.83 (dd, J = 13.8, 5.6 Hz, 1H), 1.95 (m, 
1H), 0.93 (d, J = 6.7 Hz, 3H), 0.81 (d, J = 6.6 Hz, 3H); 13C NMR (DMSO) δ 169.1, 168.6, 142.0, 132.2, 
132.1, 129.1, 123.3, 122.8, 63.5, 48.5, 27.3, 20.8, 20.4.  HRMS (ESI) calcd for C13H17N2O2 [M + H]+: 
233.1290, found: 233.1295.   
General experimental procedure to prepare 6. 
To a stirred solution of 1 (1.0 mmol) in 10 mL dry ethanol (10 mL) was added aniline 5 (1.05 mmol) and 
OSU-6 (5-wt%), followed by TMSCN (1.1 mmol) and the solution was refluxed for a period of 2 h.  The 
product precipitated as solid. The crude reaction mixture was cooled in an ice bath and filtered.  The 
filtered product was washed with cold ethanol (10 mL) and hexanes (10 mL).  After drying, the product 
was re-dissolved using hot ethyl acetate (75 mL) and filtered to remove the catalyst.  The organic layer 
was concentrated under vacuum to afford 6 in the yields shown in Table IV.    
(±)-3-(Phenylamino)isobenzofuran-1(3H)-one (6a).  Isolated as an off-white solid, mp 200-201 °C; IR: 
3457, 3289, 1720 cm-1; 1H NMR (DMSO-d6): δ 7.92 (d, J = 7.9 Hz, 1H), 7.53 (t, J = 7.6 Hz, 1H), 7.08 
(m, 4H), 6.79 (s, 1H), 6.58 (m, 4H); 13C NMR (DMSO) δ 160.8, 148.3, 142.2, 135.3, 129.8, 129.4, 122.6, 
120.2, 117.3, 114.5, 113.3, 91.1. HRMS (ESI) calcd for C14H12NO2 [M + H]+: 226.0868, found: 226.0872. 
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(±)-3-[(3-Chlorophenyl)amino]isobenzofuran-1(3H)-one (6b).  Isolated as a pale yellow solid, mp 177-
178 °C; IR: 3322, 1750 cm-1; 1H NMR (DMSO-d6): δ 7.91 (d, J = 7.8 Hz, 1H), 7.86 (d, J = 7.5 Hz, 1H), 
7.74 (m, 2H), 7.56 (d, J = 10.5 Hz, 1H), 7.25 (t, J = 8.0 Hz, 1H), 7.19 (d, J = 10.5 Hz, 1H), 7.02 (s, 1H), 
6.91 (d, J = 8.2 Hz, 1H), 6.86 (d, J = 7.8 Hz, 1H); 3C NMR (DMSO-d6): δ 169.4, 147.4, 146.0, 135.0, 
134.2, 131.2, 131.1, 127.7, 125.2, 124.6, 119.3, 114.2, 113.5, 87.6.  HRMS (ESI) calcd for C14H11ClNO2 
[M + H]+: 260.0478, found: 260.0484. 
(±)-3-[(4-Methoxyphenyl)amino]isobenzofuran-1(3H)-one (6c).  Isolated as a white solid, mp 190-191 
°C; IR: 3425, 3280, 1714 cm-1; 1H NMR (DMSO-d6): δ (ppm) 7.92 (d, J = 8.0 Hz, 1H), 7.52 (t, J = 7.5 
Hz, 1H), 7.08 (m, 2H), 6.71 (d, J = 8.6 Hz, 2H), 6.53 (d, J = 8.6 Hz, 2H), 6.48 (apparent d, J = 9.3 Hz, 
2H), 3.67 (s, 3H); 13C NMR (DMSO-d6): δ 160.9, 156.6, 151.9, 142.4, 142.2, 135.3, 129.7, 122.6, 120.3, 
115.1, 114.1, 92.0, 55.8.  HRMS (ESI) calcd for C15H14NO3 [M + H]+: 256.0974 found: 256.0981. 
(±)-3-{[4-(Trifluoromethyl)phenyl]amino}isobenzofuran-1(3H)-one (6d).  Isolated as a white solid, 
mp 214-215 °C; IR: 3344, 1736 cm-1; 1H NMR (DMSO-d6): δ 7.90 (m, 3H), 7.77 (d, J = 7.6 Hz, 1H), 7.74 
(t, J = 7.5 Hz, 1H), 7.59 (d, J = 8.3 Hz, 2H), 7.23 (d, J = 10.2 Hz, 1H), 7.11 (d, J = 8.3 Hz, 2H); 13C NMR 
(DMSO-d6): δ 169.4, 149.2, 145.9, 135.0, 131.1, 127.6, 126.9 (q, J = 4.0 Hz), 125.4 (q, J= 271.7 Hz), 
125.3, 124.6, 119.8 (q, J = 31.3 Hz), 114.5, 87.0. HRMS (ESI) calcd for C15H11F3NO2 [M + H]+: 
294.0742, found: 294.0747. 
(±)-3-[(4-Nitrophenyl)amino]isobenzofuran-1(3H)-one (6e).  Isolated as a yellow solid, mp 243-244 
°C; IR: 3322, 1750 cm-1; 1H NMR (DMSO-d6): δ 8.42 (d, J = 9.7 Hz, 1H), 8.18 (d, J = 8.8 Hz, 2H), 7.93 
(d, J = 7.6 Hz, 1H), 7.90 (t, J = 7.5 Hz, 1H), 7.80 (d, J = 7.6 Hz, 1H), 7.76 (t, J = 7.4 Hz, 1H), 7.27 (d, J = 
9.6 Hz, 1H), 7.11 (d, J = 8.8 Hz, 2H); 13C NMR (DMSO-d6): δ 169.2, 152.3, 145.6, 139.7, 135.2, 131.3, 
127.4, 126.3, 125.4, 124.7, 114.0, 86.0.  HRMS (ESI) calcd for C14H11lN2O4 [M + H]+: 271.0719, found: 
271.0725. 
(±)-2-Benzyl-1-methyl-3-oxoisoindoline-1-carbonitrile (8a).  Isolated as a white solid, mp 150-151 °C; 
IR: 2336, 1707 cm-1; 1H NMR (DMSO-d6): δ 7.99 (d, J = 7.9 Hz, 1H), 7.84 (m, 2H), 7.70 (t, J = 7.4 Hz, 
1H), 7.45-7.23 (complex, 5H), 4.85 (s, 2H), 1.86 (s, 3H); 13C NMR (DMSO-d6): δ 166.8, 144.0, 137.3, 
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134.0, 131.0, 129.7, 128.9, 128.3, 127.9, 124.2, 123.2, 118.4, 58.4, 43.6, 24.4.  HRMS (ESI) calcd for 
C17H15N2O [M + H]+: 263.1184, found: 263.1171. 
(±)-2-(4-Chlorobenzyl)-1-methyl-3-oxoisoindoline-1-carbonitrile (8b).  Isolated as a white solid, mp 
122-123 °C; IR: 2337, 1708 cm-1; 1H NMR (DMSO-d6): δ 7.99 (d, J = 7.7 Hz, 1H), 7.86 (d, J = 7.6 Hz, 
1H), 7.85 (t, J = 7.5 Hz, 1H), 7.71 (t, J = 7.5 Hz, 1H), 7.45 (d, J = 8.5 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 
4.89 (d, J = 16.1 Hz, 1H), 4.81 (d, J = 16.1 Hz, 1H), 1.89 (s, 3H); 13C NMR (DMSO) δ 166.8, 144.0, 
136.4, 134.1, 132.5, 131.0, 130.2, 129.6, 128.9, 124.2, 123.2, 118.4, 58.3, 42.8, 24.3. HRMS (ESI) calcd 
for C17H14ClN2O [M + H]+: 297.0795, found: 297.0818. 
(±)-2-(4-Fluorobenzyl)-1-methyl-3-oxoisoindoline-1-carbonitrile (8c).  Isolated as a yellow solid, mp 
123-125 °C; IR: 2238, 1710 cm-1; 1H NMR (CDCl3): δ 7.93 (d, J = 7.4 Hz, 1H), 7.70 (t, J = 7.7 Hz, 1H), 
7.62 (m, 2H), 7.40 (m, 2H), 7.04 (t, J = 8.6 Hz, 2H), 5.07 (d, J = 15.7 Hz, 1H), 4.66 (d, J = 15.7 Hz, 1H), 
1.68 (s, 3H); 13C NMR (CDCl3) δ 167.2, 162.5 (d, J = 247.5 Hz), 143.3, 133.3, 132.4, 130.5, 130.0 (d, J = 
8.0 Hz), 129.8, 124.6, 121.8, 117.5, 115.7 (d, J = 23.2 Hz), 58.5, 43.7, 25.9. HRMS (ESI) calcd for 
C17H14FN2O [M + H]+: 281.1090, found: 281.1112. 
(±)-2-Allyl-1-methyl-3-oxoisoindoline-1-carbonitrile (8d).  Isolated as a white solid, mp 71-73 °C;  IR:  
2336, 1709 cm-1; 1H NMR (DMSO-d6): δ 7.99 (d, J = 7.8 Hz, 1H), 7.81 (m, 2H), 7.68 (t, J = 7.5 Hz, 1H), 
5.93 (ddt, J = 17.1, 10.2, 5.7 Hz, 1H), 5.35 (d, J = 17.1 Hz, 1H), 5.23 (d, J = 10.2 Hz, 1H), 4.26 (d, J = 
5.7 Hz, 2H), 1.94 (s, 3H); 13C NMR (CDCl3) δ 166.7, 143.4, 133.1, 132.6, 130.4, 130.0, 124.4, 121.8, 
118.8, 117.9, 58.2, 43.4, 25.6.  HRMS (ESI) calcd for C13H13N2O [M + H]+: 213.1028, found: 213.1045. 
(±)-2-Cyclopropyl-1-methyl-3-oxoisoindoline-1-carbonitrile (8e). Isolated as a white solid, mp 159-
160 °C; IR: 2360, 1707 cm-1; 1H NMR (DMSO-d6): δ 7.95 (d, J = 7.6 Hz, 1H), 7.78 (m, 2H), 7.66 (t, J = 
7.3 Hz, 1H), 2.68 (s, 1H), 2.01 (s, 3H), 1.15 (m, 1H), 1.02 (m, 2H), 0.88 (m 1H); 13C NMR (DMSO-d6): δ 
167.3, 143.6, 134.0, 130.9, 130.3, 124.0, 123.1, 119.7, 59.1, 24.3, 23.2, 6.4, 3.9. HRMS (ESI) calcd for 
C13H13N2O [M + H]+: 213.1028, found: 213.1039. 
(±)-1-Methyl-2-(4-methylbenzyl)-3-oxoisoindoline-1-carbonitrile (8f).  Isolated as an off-white solid, 
mp 120-122 °C; IR: 2335, 1710 cm-1; 1H NMR (DMSO-d6): δ 7.97 (d, J = 7.6 Hz, 1H), 7.86 (d, J = 7.6 
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Hz, 1H), 7.81 (d, J = 7.4 Hz, 1H), 7.70 (t, J = 7.5 Hz, 1H), 7.30 (d, J = 7.6 Hz, 2H), 7.15 (d, J = 7.6 Hz, 
2H), 4.79 (s, 2H), 2.28 (s, 3H), 1.84 (s, 3H); 13C NMR (DMSO-d6) δ 166.8, 144.2, 137.0, 134.3, 134.0, 
131.0, 129.7, 129.5, 128.3, 124.1, 123.2, 118.4, 58.3, 43.3, 24.5, 21.2. HRMS (ESI) calcd for C18H17N2O 
[M + H]+: 277.1341, found: 277.1331. 
(±)-2-Benzyl-1-methyl-3-oxoisoindoline-1-carboxamide (9a).  Isolated as a white solid, mp 222-224 
°C; IR: 3302, 3157, 1682 cm-1; 1H NMR (DMSO-d6): δ 7.76 (d, J = 7.5 Hz, 1H), 7.63 (m, 2H), 7.55 (t, J = 
7.3 Hz, 1H), 7.49 (br s, 1H), 7.39-7.26 (complex, 5H), 7.23 (t, J = 7.0 Hz, 1H), 5.14 (d, J = 16.0 Hz, 1H), 
4.19 (d, J = 16.0 Hz, 1H), 1.47 (s, 3H); 13C NMR (DMSO) δ 171.5, 168.4, 147.8, 139.0, 132.6, 130.9, 
129.2, 128.7, 127.9, 127.3, 123.5, 122.1, 70.1, 44.6, 22.4.  HRMS (ESI) calcd for C17H17N2O2 [M + H]+: 
281.1290, found: 281.1242. 
(±)-2-(4-Chlorobenzyl)-1-methyl-3-oxoisoindoline-1-carboxamide (9b).  Isolated as an off-white solid, 
mp 193-195 °C; IR: 3381, 3321, 1673 cm-1; 1H NMR (DMSO-d6): δ 7.75 (d, J = 7.5 Hz, 1H), 7.64 (m, 
2H), 7.55 (t, J = 7.2 Hz, 1H), 7.49 (br s, 1H), 7.40-7.32 (complex, 5H), 5.06 (d, J = 16.3 Hz, 1H), 4.25 (d, 
J = 16.3 Hz, 1H), 1.50 (s, 3H); 13C NMR (DMSO) δ 171.4, 168.4, 147.8, 138.0, 132.7, 131.9, 130.8, 
129.9, 129.2, 128.7, 123.5, 122.1, 70.0, 43.9, 22.3. HRMS (ESI) calcd for C17H16ClN2O2 [M + H]+: 
315.0900, found: 315.0932. 
(±)-2-(4-Fluorobenzyl)-1-methyl-3-oxoisoindoline-1-carboxamide (9c).  Isolated as a white solid, mp 
201-203 °C; IR: 3342, 3181, 1672 cm-1; 1H NMR (DMSO-d6): δ 7.75 (d, J = 7.4 Hz, 1H), 7.63 (q, J = 7.7 
Hz, 2H), 7.55 (t, J = 7.1 Hz, 1H), 7.48 (br s, 1H), 7.45-7.37 (m, 2H), 7.34 (br s, 1H), 7.12 (t, J = 8.7 Hz, 
2H), 5.06 (d, J = 16.0 Hz, 1H), 4.23 (d, J = 16.0 Hz, 1H), 1.49 (s, 3H); 13C NMR (DMSO-d6) δ 171.4, 
168.4, 161.6 (d, J = 243.4 Hz), 147.8, 135.2, 132.6, 130.8, 130.0, (d, J = 8.1 Hz) 129.2, 123.5, 122.1, 
115.4 (d, J = 21.2 Hz), 70.0, 43.9, 22.4. HRMS (ESI) calcd for C17H16FN2O2 [M + H]+: 299.1196, found: 
299.1128. 
(±)-2-(3-Methoxybenzyl)-1-methyl-3-oxoisoindoline-1-carboxamide (9d).  Isolated as off a white solid, 
mp 213-215 °C; IR: 3311, 3169, 1676 cm-1; 1H NMR (DMSO-d6): δ 7.76 (d, J = 7.4 Hz, 1H), 7.63 (m, 
2H), 7.55 (t, J = 7.1 Hz, 1H), 7.48 (br s, 1H), 7.34 (br s, 1H), 7.21 (t, J = 7.9 Hz, 1H), 6.92 (s, 1H), 6.91 
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(obscured, 1H), 6.80 (dd, J = 8.1, 2.4 Hz, 1H), 5.09 (d, J = 16.1 Hz, 1H), 4.16 (d, J = 16.1 Hz, 1H), 3.71 
(s, 3H), 1.48 (s, 3H); 13C NMR (DMSO-d6): δ 171.4, 168.4, 159.7, 147.8, 140.6, 132.6, 130.9, 129.8, 
129.2, 123.5, 122.1, 120.1, 113.7, 112.7, 70.1, 55.4, 44.6, 22.4. HRMS (ESI) calcd for C18H19N2O3 [M + 
H]+: 311.1396, found: 311.1393. 
(±)-2-(4-Methoxybenzyl)-1-methyl-3-oxoisoindoline-1-carboxamide (9e).  Isolated as a white solid, mp 
168-170 °C; IR: 3291, 3157, 1675 cm-1; 1H NMR (DMSO-d6): δ 7.74 (d, J = 7.4 Hz, 1H), 7.61 (m, 2H), 
7.54 (t, J = 7.3 Hz, 1H), 7.44 (br s, 1H), 7.32 (br s, 1H), 7.28 (d, J = 8.2 Hz, 2H), 6.85 (d, J = 8.2 Hz, 2H), 
5.06 (d, J = 15.8 Hz, 1H), 4.12 (d, J = 15.8 Hz, 1H), 3.72 (s, 3H), 1.45 (s, 3H); 13C NMR (DMSO-d6): δ 
171.5, 168.3, 158.7, 147.8, 132.6, 130.9, 129.4, 129.2, 123.5, 122.0, 114.1, 70.0, 55.5, 44.0, 22.6 (1 
aromatic C unresolved).  HRMS (ESI) calcd for C18H19N2O3 [M + H]+: 311.1396, found: 311.1425. 
(±)-1-Methyl-3-oxo-2-[4-(trifluoromethyl)benzyl]isoindoline-1-carboxamide (9f).  Isolated as a white 
solid, mp 214-215 °C; IR: 3321, 3207, 1674 cm-1; 1H NMR (DMSO-d6): δ 7.76 (d, J = 7.5 Hz, 1H), 7.68-
7.62 (complex, 4H), 7.59-7.53 (m, 3H), 7.52 (br s, 1H), 7.37 (br s, 1H), 5.11 (d, J = 16.6 Hz, 1H), 4.38 (d, 
J = 16.6 Hz, 1H), 1.53 (s, 3H); 13C NMR (DMSO-d6): δ 170.8, 168.0, 147.3, 143.3, 132.2, 130.2, 128.8, 
128.1, 127.5 (q, J = 31.3 Hz), 125.3 (q, J = 3.0 Hz), 124.3 (q, J = 273.7 Hz), 123.0, 121.7, 69.6, 43.8, 
21.7.  HRMS (ESI) calcd for C18H16F3N2O2 [M + H]+: 349.1164, found: 349.1196. 
(±)-1-Methyl-3-oxo-2-(2-phenylethyl)isoindoline-1-carboxamide (9g).  Isolated as a white solid, mp 
201-202 °C; IR: 3371, 3206, 1672 cm-1; 1H NMR (DMSO-d6): δ 7.71 (d, J = 7.5 Hz, 1H), 7.61 (m, 2H), 
7.52 (t, J = 7.3 Hz, 1H), 7.38 (br s, 1H), 7.35 - 7.25 (complex, 5H), 7.22 (m, 1H), 3.84 (ddd, J = 13.9, 9.9, 
5.1 Hz, 1H), 3.31 (m, 1H), 2.99 (m, 2H), 1.59 (s, 3H); 13C NMR (DMSO-d6): δ 171.8, 168.1, 147.7, 
139.8, 132.4, 131.3, 129.2, 129.1, 128.9, 126.7, 123.2, 122.1, 69.7, 43.7, 34.6, 21.8.  HRMS (ESI) calcd 
for C18H19N2O2 [M + H]+: 295.1447, found: 295.1480. 
(±)-2-Allyl-1-methyl-3-oxoisoindoline-1-carboxamide (9h).  Isolated as a white solid, mp 223-225 °C; 
IR: 3350, 3174, 1673 cm-1; 1H NMR (400 MHz): δ 7.70 (d, J = 7.5 Hz, 1H), 7.61 (m, 2H), 7.52 (t, J = 7.3 
Hz, 1H), 7.41 (br s, 1H), 7.26 (br s, 1H), 5.91 (ddt, J = 16.7, 10.2, 5.2 Hz, 1H), 5.23 (d, J = 16.7 Hz, 1H), 
5.11 (d, J = 10.2 Hz, 1H), 4.33 (dd, J = 16.3, 5.3 Hz, 1H), 3.81 (dd, J = 16.2, 6.3 Hz, 1H), 1.66 (s, 3H); 
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13C NMR (DMSO): δ 171.7, 167.7, 147.8, 134.9, 132.5, 131.0, 129.1, 123.3, 122.0, 117.2, 69.6, 43.7, 
22.2. HRMS (ESI) calcd for C13H15N2O2 [M + H]+: 231.1134, found: 231.1195. 
(±)-2-Cyclopropyl-1-methyl-3-oxoisoindoline-1-carboxamide (9i).  Isolated as a white solid, mp 238-
240 °C; IR: 3369, 3205, 1675 cm-1; 1H NMR (DMSO-d6): δ 7.67 (d, J = 7.5 Hz, 1H), 7.61 (t, J = 7.4 Hz, 
1H), 7.50 (overlapping d and t, J = 7.7 Hz, 2H), 7.29 (br s, 1H), 7.14 (br s, 1H), 2.55 (m, 1H), 1.72 (s, 
3H), 0.96 (m, 2H), 0.85 (m, 1H), 0.67 (m, 1H); 13C NMR (DMSO-d6): δ 172.7, 169.6, 148.1, 132.6, 
131.4, 129.1, 123.4, 121.6, 69.8, 23.8, 21.6, 6.4, 3.3. HRMS (ESI) calcd for C13H15N2O2 [M + H]+: 
231.1134, found: 231.1122. 
(±)-2-Ethyl-1-methyl-3-oxoisoindoline-1-carboxamide (9j).  Isolated as a white solid, mp 228-230 °C; 
IR: 3336, 3166, 1672 cm-1; 1H NMR (DMSO-d6): δ 7.67 (d, J = 7.5 Hz, 1H), 7.59 (m, 2H), 7.51 (t, J = 7.2 
Hz, 1H), 7.34 (br s, 1H), 7.23 (br s, 1H), 3.67 (dq, J = 14.4, 7.2 Hz, 1H), 3.23 (dq, J = 14.4, 7.2 Hz, 1H), 
1.69 (s, 3H), 1.20 (t, J = 7.1 Hz, 3H); 13C NMR (DMSO-d6): δ 171.9, 167.7, 147.8, 132.3, 131.4, 129.1, 
123.1, 122.0, 69.5, 36.0, 22.0, 14.4.  HRMS (ESI) calcd for C12H15N2O2 [M + H]+: 219.1134, found: 
219.1149. 
(±)-1-Methyl-2-(4-methylbenzyl)-3-oxoisoindoline-1-carboxamide (9k).  Isolated as a white solid, mp 
190-191 °C; IR: 3294, 3192, 1672 cm-1; 1H NMR (DMSO-d6): δ 7.75 (d, J = 7.4 Hz, 1H), 7.62 (m, 2H), 
7.55 (t, J = 7.3 Hz, 1H), 7.45 (br s, 1H), 7.33 (br s, 1H), 7.22 (d, J = 7.7 Hz, 2H), 7.10 (d, J = 7.7 Hz, 2H), 
5.09 (d, J = 16.0 Hz, 1H), 4.12 (d, J = 16.0 Hz, 1H), 2.26 (s, 3H), 1.44 (s, 3H); 13C NMR (DMSO-d6): δ 
171.5, 168.3, 147.8, 136.4, 135.9, 132.6, 130.9, 129.3, 129.2, 127.9, 123.5, 122.1, 70.0, 44.3, 22.5, 21.1.  
HRMS (ESI) calcd for C18H19N2O2 [M + H]+: 295.1447, found: 295.1462. 
(±)-2-Cyclohexyl-1-methyl-3-oxoisoindoline-1-carboxamide (9l).  Isolated as a white solid, mp 256-
257 °C; IR: 3316, 3186, 1668 cm-1; 1H NMR (DMSO-d6): δ 7.60 (m, 2H), 7.49 (m, 2H), 7.28 (br s, 1H), 
7.24 (br s, 1H), 3.21 (m, 1H), 2.33 (m, 1H), 2.12 (m, 1H), 1.94 (m, 1H), 1.72 (m, 4H), 1.67 (s, 3H), 1.30 
(m, 1H), 1.17 (m, 2H); 13C NMR (DMSO-d6): δ 171.9, 167.5, 147.7, 132.4, 132.1, 128.9, 123.1, 121.7, 
70.2, 54.6, 30.4, 29.6, 26.4, 26.1, 25.7, 22.3. HRMS (ESI) calcd for C16H21N2O2 [M + H]+: 273.1603, 
found: 273.1586. 
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(±)-2-Hexyl-1-methyl-3-oxoisoindoline-1-carboxamide (9m).  Isolated as a white solid, mp 163-165 
°C; IR: 3357, 3185, 1673 cm-1; 1H NMR (DMSO-d6): δ 7.66 (d, J = 7.5 Hz, 1H), 7.59 (m, 2H), 7.51 (t, J = 
7.2 Hz, 1H), 7.33 (br s, 1H), 7.25 (br s, 1H), 3.58 (m, 1H), 3.12 (m, 1H), 1.73 (m, 1H), 1.68 (s, 3H), 1.55 
(m, 1H), 1.29 (m, 6H), 0.88 (distorted t, J = 6.6 Hz, 3H); 13C NMR (DMSO-d6): δ 171.9, 167.9, 147.7, 
132.3, 131.4, 129.0, 123.2, 122.0, 69.5, 41.5, 31.5, 28.6, 26.9, 22.5, 22.0, 14.4. HRMS (ESI) calcd for 
C16H23N2O2 [M + H]+: 275.1760, found: 275.1739. 
(±)-2-Isobutyl-1-methyl-3-oxoisoindoline-1-carboxamide (9n).  Isolated as a white solid, mp 193-194 
°C; IR: 3349, 3189, 1678 cm-1; 1H NMR (DMSO-d6): δ 7.67 (d, J = 7.5 Hz, 1H), 7.59 (m, 2H), 7.51 (t, J = 
7.2 Hz, 1H), 7.33 (br s, 1H), 7.29 (br s, 1H), 3.46 (dd, J = 14.1, 7.8 Hz, 1H), 2.92 (dd, J = 14.1, 7.6 Hz, 
1H), 2.14 (nonet, J = 6.9 Hz, 1H), 1.70 (s, 3H), 0.89 (d, J = 6.7 Hz, 6H); 13C NMR (DMSO-d6): δ 171.7, 
168.6, 147.7, 132.3, 131.4, 129.0, 123.3, 122.0, 69.8, 49.0, 27.7, 22.1, 21.1, 20.9. HRMS (ESI) calcd for 
C14H19N2O2 [M + H]+: 247.1447, found: 247.1481.  
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